The Gulf States Hemophilia and Thrombophilia Center (GSHTC), as part of the University of Texas Health Science Center Houston Medical School, Department of Pediatrics, is a federally funded hemophilia treatment center (HTC) that provides comprehensive care to over 700 pediatric and adult patients with bleeding and clotting disorders.
The Center is dedicated to providing the best and most clinically advanced care to persons with hemophilia, von Willebrand disease, and other bleeding and clotting disorders. To maintain this standard of excellence, GSHTC has an experienced team of professionals dedicated to providing comprehensive care to a culturally diverse population of children, adults and their families.
The Center also operates as the coordinating center for the Maternal and Child Health Bureau (MCHB) and Centers for Disease Control (CDC) Great Plains Region. As such our Center has oversight for 16 hemophilia treatment centers in the states of Oklahoma, Louisiana, Arkansas, Kansas, Nebraska, Iowa, Missouri, and Texas.
The Gulf States Hemophilia and Thrombophilia Center (GSHTC) is dedicated to providing the best and most clinically advanced care to persons with hemophilia, Von Willebrand disease, and other bleeding and clotting disorders. We have been providing this care since 1977. To maintain this standard of excellence, GSHTC has an experienced team of professionals dedicated to providing comprehensive care to a culturally diverse population of children, adults, and their families.
Our Center is part of a nationwide network of HTCs that provide a range of comprehensive services. Hemophilia Treatment Centers provide efficient use of resources and offer multidisciplinary services in one location. This model incorporates the concept of treating the whole person and his or her family by case management of the medical and psychological issues related to hemophilia or other bleeding and clotting disorders.
The treatment of hemophilia consists of the use of clotting factors which replace the missing protein that the body needs to stop or prevent bleeding. Each patient’s treatment is unique and prescribed by a physician.
Comprehensive care is provided by a team of professionals with expertise in bleeding, clotting, and blood-related disorders. The team includes a hematologist, nurse coordinators, medical social worker, physical therapist, dentist, geneticist, pharmacist, and research coordinator. Comprehensive Care is a proven, effective treatment model used in healthcare that provides services in a coordinated, proactive manner to improve health and quality of life.
The Gulf States Pharmacy is a specialty pharmacy that was established in 1995 to provide clotting factor and related products to the patients of The Gulf States Hemophilia and Thrombophilia Center through a federal discount program. This program referred to as the 340B Drug Pricing Program or PHS (Public Health Service).